教職人員
|
| 最高學歷 | : | Ph.D. in Pharmacy Administration (now named Pharmacy Systems, Outcomes and Policy), University of Illinois at Chicago, Illinois, USA (2008/8-2013/8) M.S. in Clinical Pharmacy, National Taiwan University (2001/9-2003/6) B.S. in Pharmacy, National Taiwan University (1997/9-2001/6) |
| 經歷 | : | 2019.8- present Deputy Director, Department of Pharmacy, National Taiwan University Hospital Senior Health Economics and Outcomes Research Consultant, Pharmerit International, Bethesda, Maryland, USA (2014/8-2015/1) Outcomes Scientist, Pharmerit International, Bethesda, Maryland, USA (2013/8-2014/8) Summer Intern, Global Health Economics and Outcomes Research, Abbott Laboratories, Abbott Park, Illinois, USA (2010/5-2010/8) Preceptor, Clinical Rotated Teaching, Graduate Institute of Clinical Pharmacy, National Taiwan University (2004/7-2006/12) Pharmacist, National Taiwan University Hospital (2003/7-2007/4)(as Clinical Pharmacist in general surgical intensive care unit during 2004/7-2006/12) |
| 榮譽 | : | 2012 Dean’s Scholar Award (2012-2013), University of Illinois at Chicago (UIC), Illinois, USA 2012 Charles P. Bondy Memorial Scholarship, UIC College of Pharmacy 2012 Member, UIC Chapter, Phi Kappa Phi Honor Society 2011 Member, UIC Phi Chapter, Rho Chi Pharmacy Honor Society 2010 Al Langerman Memorial Scholarship, UIC College of Pharmacy |
| 研究領域 | : | 藥物流行病學、藥事經濟學、病人報告結果研究、健康照護研究 |
| 研究方向 | : | 藥物治療成效及安全性評估 病人報告結果(包含健康相關生活品質與服藥順從性) 用藥安全改善 醫療科技成本效益及財務衝擊評估 |
| 研究室要求 | : | 誠實、積極、負責、有學習熱忱 |
| 招生名額 | : | 臨床藥學研究所碩士班及博士班學生 |
Evaluating the potential of waist-to-BMI ratio, a body shape index, and other anthropometric parameters in predicting cardiovascular disease mortality: evidence from NHANES III
(2025-05-17) Lee, Thung-Lip ; Lin, Fang-Ju ; Yeh, Chih-Fan ; Hsiao, Yu-Chung ; Yang, Kai-Chien ; Hsuan, Chin-Feng ; CHAU-CHUNG WU
Predicting outcomes after hospitalisation for COPD exacerbation using machine learning.
(2025-05) Wu, Chih-Ying ; Hsu, Chien-Ning ; Wang, Charlotte ; JUNG-YIEN CHIEN ; CHI-CHUAN WANG ; FANG-JU LIN
Reassessing LDL-C thresholds: Toward tailored lipid management
(2025-05) Hsiao, Yu-Chung ; Chen, Tzu-Yang ; Lin, Fang-Ju ; CHAU-CHUNG WU
The Impact of QT-Prolonging Medications and Drug-Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case-Crossover Study.
(2025-02) Chien, Hsiu-Ting ; FANG-JU LIN ; JYH-MING JIMMY JUANG ; SHU-WEN LIN
Development and validation of a five-year cardiovascular risk assessment tool for Asian adults aged 75 years and older
(2025-01-08) Hsu, Meng-Chen ; Fu, Yu-Hua ; Wang, Chi-Chuan ; CHAU-CHUNG WU ; Lin, Fang-Ju
(2025-05-17) Lee, Thung-Lip ; Lin, Fang-Ju ; Yeh, Chih-Fan ; Hsiao, Yu-Chung ; Yang, Kai-Chien ; Hsuan, Chin-Feng ; CHAU-CHUNG WU
Predicting outcomes after hospitalisation for COPD exacerbation using machine learning.
(2025-05) Wu, Chih-Ying ; Hsu, Chien-Ning ; Wang, Charlotte ; JUNG-YIEN CHIEN ; CHI-CHUAN WANG ; FANG-JU LIN
Reassessing LDL-C thresholds: Toward tailored lipid management
(2025-05) Hsiao, Yu-Chung ; Chen, Tzu-Yang ; Lin, Fang-Ju ; CHAU-CHUNG WU
The Impact of QT-Prolonging Medications and Drug-Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case-Crossover Study.
(2025-02) Chien, Hsiu-Ting ; FANG-JU LIN ; JYH-MING JIMMY JUANG ; SHU-WEN LIN
Development and validation of a five-year cardiovascular risk assessment tool for Asian adults aged 75 years and older
(2025-01-08) Hsu, Meng-Chen ; Fu, Yu-Hua ; Wang, Chi-Chuan ; CHAU-CHUNG WU ; Lin, Fang-Ju
Leveraging Natural Language Processing and Machine Learning Technologies to Early Detect Cancer Treatment Associated Cardiotoxicity in Lung Cancer Patients( I )
(2022-08-01～) FANG-JU LIN
Exploring the Link between Xanthine Oxidase Inhibitors and Risk of Heart Failure: Clinical Validation and Potential Molecular Mechanisms
(2021-08-01～) FANG-JU LIN
Urate Lowering Therapy and Risks of Cardiovascular Diseases: Insights from Clinical Evidence to Molecular Mechanisms
(2020-08-01～) FANG-JU LIN
Statins for Primary Prevention of Cardiovascular Diseases among the Elderly- an Explanatory Research
(2019-08-01～) FANG-JU LIN
Evaluation of Budget Impact Analysis for New Drug Reimbursement Decision Making
(2018-03-01～) FANG-JU LIN
(2022-08-01～) FANG-JU LIN
Exploring the Link between Xanthine Oxidase Inhibitors and Risk of Heart Failure: Clinical Validation and Potential Molecular Mechanisms
(2021-08-01～) FANG-JU LIN
Urate Lowering Therapy and Risks of Cardiovascular Diseases: Insights from Clinical Evidence to Molecular Mechanisms
(2020-08-01～) FANG-JU LIN
Statins for Primary Prevention of Cardiovascular Diseases among the Elderly- an Explanatory Research
(2019-08-01～) FANG-JU LIN
Evaluation of Budget Impact Analysis for New Drug Reimbursement Decision Making
(2018-03-01～) FANG-JU LIN